Triple Negative Breast Cancer
Triple-negative breast cancer: treatment challenges and solutions
15
RNF181 modulates Hippo signaling and triple negative breast cancer progression
11
Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer
15
Clinicopathological Characteristics of Basal Type Breast Cancer in Triple Negative Breast Cancer
5
Novel therapeutic strategies for patients with triple-negative breast cancer
10
Roles of eIF3m in the tumorigenesis of triple negative breast cancer
16
Radiological diagnostics of triple negative breast cancer: a review
9
Triple-negative breast cancer: new perspectives for targeted therapies
17
Osthole inhibits triple negative breast cancer cells by suppressing STAT3
11
Immunotherapeutic interventions of Triple Negative Breast Cancer
19
Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer
13
Comparative antiproliferative effects of iniparib and olaparib on a panel of triple negative and non triple negative breast cancer cell lines
9
Identification of candidate genes associated with triple negative breast cancer
14
Approach to the Triple Negative Breast Cancer in new drugs area
5
The clinical promise of immunotherapy in triple-negative breast cancer
11
Androgen receptor expression in triple-negative breast cancer
80
Update on triple-negative breast cancer: prognosis and management strategies
10
Recent advances in nanotheranostics for triple negative breast cancer treatment
22
Controversial issues in the neoadjuvant treatment of triple-negative breast cancer.
15
Triple negative breast cancer: an Indian perspective
5